Iron Absorption From a Micronutrient Powder Containing Galacto-oligosaccharides (GOS)
Launched by SWISS FEDERAL INSTITUTE OF TECHNOLOGY · Jan 24, 2016
Trial Information
Current as of July 03, 2025
Completed
Keywords
ClinConnect Summary
Iron absorption from two iron-fortified maize-based test meals will be measured in two groups of 40 infants (total N=80). Infants will be recruited at Msambweni District Hospital and communities served by Msambweni District Hospital in southern coastal Kenya. In group 1, iron absorption is measured after 3 weeks of MNP consumption containing 5 mg iron in form of NaFeEDTA (2.5 g) and FeFum (2.5 g) but no GOS. In group 2, iron absorption is measured after 3 weeks of MNP consumption containing 5 mg iron in form of NaFeEDTA (2.5 g) and FeFum (2.5 g) and 7.5 g GOS. Iron absorption is measured as...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age of 6-14 months at baseline
- • Assessment of good health as assessed by professional staff at Msambweni District Hospital
- • Willingness of their caregiver to provide informed consent
- Exclusion Criteria:
- • Hemoglobin \<70 g/L ; these infants will be referred for treatment according to local standard of care.
- • Severe underweight (Z-score weight-for-age \<-3) and /or severe wasting (Z-score weight-for-height\<-3)
- • Chronic or acute illness or other conditions that in the opinion of the Principle Investigator (PI) or co-researchers would jeopardize the safety or rights of a participant in the trial or would render the participant unable to comply with the protocol
- • Participants taking part in other studies requiring the drawing of blood
- • Participants who are taking iron-containing food supplements or tablets/drops
- • Participants who are taking antibiotics
About Swiss Federal Institute Of Technology
The Swiss Federal Institute of Technology (ETH Zurich) is a prestigious research university located in Switzerland, renowned for its cutting-edge scientific research and innovation. With a strong emphasis on interdisciplinary collaboration, ETH Zurich leverages its expertise in engineering, natural sciences, and technology to advance healthcare solutions through clinical trials. The institute is committed to improving patient outcomes and advancing medical knowledge by conducting rigorous, ethically-sound research that adheres to the highest standards of scientific integrity. Its distinguished faculty and state-of-the-art facilities position ETH Zurich as a leader in clinical research, fostering partnerships that bridge academia, industry, and healthcare institutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Msambweni, Kwale County, Kenya
Patients applied
Trial Officials
Michael Zimmermann, MD
Principal Investigator
Swiss Federal Institute of Technology (ETH), Zurich
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials